we undertook a multiple-dose study of the disposition of clindamycin phosphate and clindamycin , given either as 600 mg intravenously every 6 h or 1,200 mg intravenously every 12 h for five and three doses , respectively , in six healthy volunteers .
C0055881
clindamycin phosphate
C0008947
clindamycin